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Abstract
Background: The influence of different diagnostic thresholds for gestational diabetes mellitus (GDM) on pregnancy
outcomes is not fully understood. Degrees of glucose intolerance according to the Carpenter-Coustan (CC) criteria
were less severe than the National Diabetes Data Group (NDDG) criteria for GDM. Recent studies have shown
inconsistent results regarding the risk of adverse pregnancy outcomes between the NDDG and CC criteria.
Therefore, the objective of this study was to investigate whether pregnant women who met only the CC criteria
but not the NDDG criteria and those who met the NDDG criteria had increased risks of adverse pregnancy
outcomes compared to a negative screening group.
Methods: A total of 11,486 Taiwanese pregnancies were enrolled in a retrospective cohort study. The study
subjects were classified as follows: (1) negative screening group: women with negative 50-g glucose challenge test
(GCT) results, (2) false-positive screening group: women with positive GCT results and negative 100-g OGTT results
according to both CC and NDDG criteria, (3) CC-only-GDM group: women with positive GCT results plus GDM
diagnosis meeting the CC but not the NDDG criteria, and (4) NDDG-GDM group: women diagnosed with GDM
using the NDDG criteria. Multiple mixed effects logistic regression analysis was used to examine the relationships
between the groups and pregnancy outcomes.
Results: There were 9002 (78.4 %), 1776 (15.5 %), 251 (2.2 %), and 457 (4.0 %) study pregnancies in the 4 groups.
Compared with the negative screening group, the maternal outcomes were not different within groups except for
gestational hypertension/preeclampsia. For neonatal outcomes, the CC-only-GDM group had significantly greater
risks of macrosomia, low birth weight, and admission to a neonatal intensive care unit [adjusted odds ratio (aOR),
(95 % confidence interval, CI): 2.73 (1.18–6.31), 1.64 (1.01–2.64), and 1.61 (1.05–2.46), respectively]. The NDDG-GDM
group also showed significantly greater risks, and the false-positive screening group showed no differences from
the negative screening group.
Conclusion: Women who met only the CC criteria and women who met NDDG criteria had significant increased
risks of adverse neonatal outcomes. This evidence adds important information to the current debate about the
diagnostic criteria for GDM regarding pregnancy outcomes.
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Background
The prevalence of gestational diabetes mellitus (GDM)
ranges between 0.7 and 10.1 % according to different
diagnostic criteria worldwide [1–4]. Although the early
detection of GDM is important for reducing adverse
pregnancy outcome, its diagnosis remains controversial
[5–8]. In 2001, the American College of Obstetricians
and Gynecologists (ACOG) recommended a two-step
approach: a 50-g, 1-h glucose challenge test (GCT) and
a 100-g, 3-h oral glucose tolerance test (OGTT) for
pregnant women with a positive GCT [9]. Two diagnostic
criteria, the National Diabetes Data Group (NDDG) criteria
[10] and the Carpenter-Coustan (CC) criteria [11] for the
100-g OGTT could be used. In our hospital, GDM is diag-
nosed according to the NDDG criteria when two or more
plasma glucose levels exceed or are equal to 105, 190, 165,
and 145 mg/dL for the fasting, 1-, 2- and 3-h plasma glu-
cose tests, respectively [10]. The glucose levels described in
the CC criteria are 95, 180, 155, and 140 mg/dL for the fast-
ing, 1-, 2- and 3-h plasma glucose tests, respectively [11].
In 2010, the International Association of Diabetes and
Pregnancy Study Groups (IADPSG) developed new diag-
nostic criteria that are based on the Hyperglycemia and
Adverse Pregnancy Outcome (HAPO) [5, 6]. The ACOG
subsequently reaffirmed its recommendation of the two-
step approach because of concerns about a new one-step
approach, which showed no evidence of improving preg-
nancy outcomes and would significantly increase health
care costs [7, 12]. Recently, ADA indicated that GDM
screening can be accomplished using either of two
strategies: the one-step 2-h 75-g OGTT or the two-step
approach with a 1-h 50-g GCT followed by a 3-h 100-g
OGTT for those who were GCT-positive.
Despite the different recommendations for the diag-
nostic threshold of GDM, the two-step approach re-
mains commonly used worldwide. However, both the
NDDG and CC criteria have been used, and the ACOG
has not recommended either set of criteria over the
other [13]. The National Institutes of Health (NIH)
consensus development conference also recommends the
use of the two-step approach with a 100-g OGTT using
the CC or NDDG criteria [14].
Recent studies have attempted to determine whether
the use of CC criteria or NDDG criteria affect pregnancy
outcome but showed inconsistent results regarding the
risk of adverse pregnancy outcome between the NDDG
and CC criteria [15–20]. Additional file 1: Table S1 is a
brief summary of these results. Thus, it was important
to determine and understand the prevalence and risk for
pregnant women with GDM who were diagnosed based
only on the CC criteria (not on the NDDG criteria).
Therefore, our main hypothesis was that the risk of ad-
verse pregnancy outcome in women who were diagnosed
with GDM based only on the CC criteria but not meet-
ing the NDDG criteria was significantly higher than the
risk in women who screened as negative based on the
GCT. The second hypothesis was that there was an in-
creased risk of adverse pregnancy outcome in women
with GDM according to the NDDG criteria and that
there was no difference in women with false-positive
screening compared to women with negative 50-g GCT
results.
Methods
Study participants and data collection
This retrospective cohort study collected laboratory data
and medical records from pregnant women who were
administered a 50-g GCT at 24 to 28 weeks of gestation
and were delivered at the Ditmanson Medical Founda-
tion Chia-Yi Christian Hospital (DMF-CYCH) between
March 2006 and January 2013. Women with multifetal
pregnancies, pre-existing diabetes, and pre-existing
hypertension were excluded. This study was approved
by the Institutional Review Board of the DMF-CYCH
(CYCH IRB No: 100006). Plasma glucose levels were
measured using a Hitachi 7170 automatic analyzer (Hitachi
Co., Tokyo, Japan) at the DMF-CYCH central laboratory
according to a standard clinical protocol.
Two-stage approach for GDM screening and the
classification of study participants
The study included all women who underwent the two-
step approach for screening and diagnosing GDM during
the study period. The GCT was considered negative if the
screening value was <140 mg/dL. If the GCT was positive,
the women subsequently underwent a 100-g, 3-h OGTT
to confirm GDM. Study subjects were classified as follows:
(1) negative screening group: women with negative GCT
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results, (2) false-positive screening group: women with
positive GCT results and negative 100-g OGTT results ac-
cording to both CC and NDDG criteria, (3) CC-only-
GDM group: women with positive GCT results plus GDM
diagnosis meeting the CC but not the NDDG criteria, and
(4) NDDG-GDM group: women diagnosed with GDM
using the NDDG criteria.
Pregnancy outcomes: neonatal and maternal outcomes
The measured pregnancy outcomes included adverse
neonatal outcomes (including macrosomia (>4000 g),
preterm labor (delivery before 37 weeks), low birth weight
(<2500 g), admission to neonatal intensive care (NICU),
and Apgar scores <7 at 1/5 min) and maternal outcomes
(including cesarean section, gestational hypertension or
preeclampsia, shoulder dystocia, third- or fourth-degree
perineal laceration, and postpartum hemorrhage). Ges-
tational hypertension was defined as blood pressure
≥140 mmHg systolic or ≥90 mmHg diastolic after
20 weeks of gestation in a woman with previously normal
blood pressure and blood pressure levels that returned to
normal postpartum. Preeclampsia was characterized by
gestational hypertension and proteinuria (≥0.3 g/day or
≥1+ on a urine dipstick) with or without pathologic
edema [21].
Statistical analysis
In total, 9580 women and 11,468 pregnancies were en-
rolled in the study. Among the women, 1814 (18.9 %)
were recruited more than once because of multi-gravidity
during the study period. Therefore, the difference among
the glucose level groups was evaluated using the SAS
SURVEYFREQ, SURVEYMEANS and SURVEYREG pro-
cedures. Data was clustered according to subject, and the
variance of proportion was estimated using the Taylor
series linearization method. The Rao-Scott chi-square test
was used to test the categorical variables. The Wald F test
was used for continuous data. Multiple mixed effects lo-
gistic regressions were used to determine the relationships
between pregnancy outcome and glucose level group after
adjusting for nulliparity, maternal age, body mass index
(BMI) at delivery, and delivery year. In addition to the
above confounding factors, delivery type (Cesarean section
or not) was added and adjusted for the maternal outcome
of postpartum hemorrhage. The associations found were
described in terms of the adjusted odds ratio (aOR) with a
95 % confidence interval (CI). Logistic regression is widely
used to adjust for confounders, not only in case-control
studies, but also in cohort studies, yielding an aOR that
approximates the adjusted relative risk when the disease is
rare (<10 % incidence) [22, 23]. In addition, we reviewed
previous studies that are listed in the PubMed and
Cochrane databases; 6 large-sample size studies reported
the issue, and 4 of these articles used multiple logistic
regressions to estimate risk. For comparison, we used
logistic rather than Poisson regression. A two-sided p
value < 0.05 was considered statistically significant. All
data were merged and analyzed using SAS 9.2 (SAS
Institute, Cary, NC, USA). Our study adheres to the
STROBE (Strengthening the Reporting of Observational
Studies in Epidemiology) guidelines.
Results
A total of 12,274 pregnancies who received a GCT at 24
to 28 weeks of gestation and who delivered at DMF-
CYCH were enrolled. Among the cases, 289 women with
multifetal pregnancies, pre-existing diabetes, and pre-
existing hypertension were excluded; information on
height or weight at delivery was missing for 22 pregnan-
cies. An additional 477 pregnancies were excluded from
the analysis due to incomplete OGTT data. Thus, a total
of 11,486 pregnancies were included in the study; of these,
9002 (78.4 %) screened negative, 1776 (15.5 %) screened
false-positive, 251 (2.2 %) had CC-only-GDM, and 457
(4.0 %) had NDDG-GDM (Fig. 1). The characteristics of
Fig. 1 Flowchart of the study population. Footnote: GCT = glucose
challenge test; DMF-CYCH = Ditmanson Medical Foundation Chia-Yi
Christian Hospital; OGTT = oral glucose tolerance test; GDM=gestational
diabetes mellitus; CC = Carpenter-Coustan criteria; NDDG = National
Diabetes Data Group criteria
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the study population among the 4 groups are shown in
Table 1. The distributions differed among these groups.
Table 2 shows that the neonatal outcomes were signifi-
cantly associated with the 4 groups, including macrosomia
(0.8 to 3.5 %, P < 0.001), preterm labor (6.5 to 12.3 %,
P < 0.001), low birth weight (5.6 to 9.0 %, P = 0.01),
and NICU admission (6.5 to 12.7 %, P < 0.001); all of
these conditions presented significantly higher inci-
dence rates with higher glucose levels. The incidences
of the maternal outcomes did not differ among the 4
glucose level groups, except for total cesareans (30.2
to 42.2 %, P < 0.001) and gestational hypertension or
preeclampsia (2.8 to 7.0 %, P < 0.001), for which the
incidence increased with glucose level.
Table 3 shows the odds ratios of the outcomes after
adjusting for confounding factors. Compared with the
negative screening group, women with CC-only-GDM
had significantly higher odds of macrosomia (aOR, 2.73;
95 % CI, 1.18–6.31), low birth weight (aOR, 1.64; 95 % CI,
1.01–2.64), and NICU admission (aOR, 1.61; 95 % CI,
1.05–2.46). The NDDG-GDM group also showed signifi-
cant results with greater aOR (95 % CI): 3.15 (1.71–5.80),
1.81 (1.28–2.56), and 1.98 (1.47–2.68), respectively. The
false-positive screening group did not differ from the
negative screening group. Maternal outcomes did not sig-
nificantly differ in the multivariable analyses, with the ex-
ceptions of gestational hypertension and preeclampsia.
Discussion
Our result was concordant with other studies that use of
the CC criteria of 100-g OGTT in the two-step approach
increased the prevalence of GDM. Previous studies com-
paring the NDDG and CC criteria were conducted in
the Eastern U.S. [20], Western U.S. [16, 18], Canada
[15], Spain [17], Turkey [24], and Taiwan [19]. The in-
crease in prevalence of GDM in our study was similar to
that found in two large sample studies [16, 18]. The GDM
prevalence increased from 31.8 to 125.7 % (Additional file
1: Table S1) using the CC criteria compared with the
NDDG criteria, possibly due to differences in ethnicity,
lifestyle, or policies.
The findings of the study agreed with previous studies
in that the additional patients that are diagnosed by CC-
only-GDM criteria are at higher risk of adverse pregnancy
outcome [15, 16, 18, 20]. In addition to fetal macrosomia,
the pregnant women who were diagnosed based on CC-
only-GDM criteria were also at significantly increased risk
of low birth weight and admission to NICU; these rep-
resent new findings (Additional file 1: Table S1). Our
findings provide important additional information to the
current debate about the diagnostic criteria for GDM re-
garding pregnancy outcome [25].
Although the incidence of macrosomia in the study
was lower than that found in other studies [15–20], the
rate remained significantly higher in the CC-only-GDM
group than in the screening negative group. After adjusting
for confounding factors, macrosomia remained a greater
risk, consistent with the data reported by Berggren et al.
[20]. However, a study in Spain did not yield significant
findings [17].
For other neonatal outcomes, our results also showed
strong evidence of significantly increased risks of low
birth weight and admission NICU, and weak evidence of
increased risk of preterm labor. Regarding the risk of
NICU admission, two U.S. studies showed no association
with the CC-only group [18, 20]; however, our data showed
a significant association. Regarding low birth weight, the
study of Berggren et al. showed no significant risk; however,
our study showed a 1.6-fold higher risk compared to the
screening negative group [20]. Regarding preterm labor,
previous studies showed no significant association after
adjusting for confounding factors [17, 18, 20], with the ex-
ception of Hedderson et al. [16]. Our result regarding pre-
term labor was similar to that reported by Hedderson et al.,
and the adjusted odds ratios were 1.53 (0.99–2.37) and 1.53
(1.16–2.03), respectively.
Table 1 Characteristics of the study population
Negative screening False-positive screening CC-only-GDM (not meeting NDDG) NDDG-GDM P
Number of observations 9002 1776 251 457
Number of clusters 7640 1699 249 434
Nulliparous status
Yes 4627 (51.4) 936 (52.7) 115 (45.8) 212 (46.4) 0.03a
No 4375 (48.6) 840 (47.3) 136 (54.2) 245 (53.6)
Maternal age (years) 29.0 (28.9–29.1) 30.6 (30.4–30.8) 32.1 (31.5–32.6) 32.5 (32.0–32.9) <0.001b
BMI at delivery (kg/m2) 26.7 (26.6–26.8) 27.2 (27.0–27.4) 28.2 (27.8–28.7) 28.1 (27.7–28.5) <0.001b
50-g GCT levels (mg/dL) 110.4 (110.0–110.7) 158.0 (157.3–158.7) 164.8 (162.4–167.3) 179.7 (177.0–182.3) <0.001b
Data are presented as means (95 % confidence interval) or n (%)
CC Carpenter-Coustan criteria, GDM gestational diabetes mellitus, NDDG National Diabetes Data Group criteria; BMI body mass index, GCT glucose challenge test
aThe Rao-Scott chi-square test was performed using SAS SURVEYFREQ produces
bANOVA was performed using SAS SURVEYREG produces the Wald F test with their corresponding p-values
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In contrast, regarding adverse maternal outcomes, our
results showed that Cesarean section, gestational hyper-
tension and preeclampsia exhibited increasing incidence
as glucose levels increased from the screening negative
group to the NDDG-GDM group; however, the findings
did not reach statistical significance in the CC-only-GDM
group after adjusting for confounding factors. These re-
sults were different than those obtained in previous stud-
ies, which showed that the incidence of cesarean section
[15, 16, 18, 20], gestational hypertension, and preeclampsia
[16, 17, 20] was higher in the CC-only-GDM group. We
speculated that this result might have been influenced by
Table 2 Pregnancy outcomes associated with the 4 glucose level groups













Macrosomia (>4000 g) 120/11,486 75 (0.8) 22 (1.2) 7 (2.8) 16 (3.5) 39.0 <0.001
Preterm labor (<37 weeks) 789/11,486 581 (6.5) 127 (7.2) 25 (10.0) 56 (12.3) 27.0 <0.001
Low birth weight (<2500 g) 673/11,486 507 (5.6) 105 (5.9) 20 (8.0) 41 (9.0) 10.9 0.01
Admission to NICUa 789/11,471 584 (6.5) 121 (6.8) 26 (10.4) 58 (12.7) 31.1 <0.001
Apgar score <7 at 1 min 127/11,486 99 (1.1) 17 (1.0) 4 (1.6) 7 (1.5) 1.7 0.64
Apgar score <7 at 5 min 37/11,486 28 (0.3) 8 (0.5) - 1 (0.2) - -
Maternal outcome
Cesarean section 3632/11,486 2721 (30.2) 617 (34.7) 101 (40.2) 193 (42.2) 46.3 <0.001
Gestational hypertension
or preeclampsia
383/11,486 255 (2.8) 82 (4.6) 14 (5.6) 32 (7.0) 38.6 <0.001
Shoulder dystociab 79/7854 64 (1.0) 7 (0.6) 3 (2.0) 5 (1.9) 5.5 0.14
Third- or fourth-degree
perineal lacerationb
429/7854 337 (5.4) 69 (6.0) 9 (6.0) 14 (5.3) 0.7 0.86
Postpartum hemorrhage 98/11,486 76 (0.8) 16 (0.9) 3 (1.2) 3 (0.7) 0.6 0.89
Data are presented as n (%)
CC Carpenter-Coustan criteria, GDM gestational diabetes mellitus, NDDG National Diabetes Data Group criteria, NICU neonatal intensive care unit
The Rao-Scott Chi-Square test was performed
aExcluding neonatal death
bOnly including vaginal delivery










Macrosomia (>4000 g) 1 1.30(0.79–2.15) 2.73(1.18–6.31)c 3.15(1.71–5.80)c
Preterm labor (<37 weeks) 1 1.09(0.89–1.34) 1.53(0.99–2.37) 1.90(1.39–2.58)c
Low birth weight (<2500 g) 1 1.07(0.85–1.33) 1.64(1.01–2.64)c 1.81(1.28–2.56)c
Admission to NICUa 1 1.02(0.83–1.25) 1.61(1.05–2.46)c 1.98(1.47–2.68)c
Apgar score <7 at 1 min 1 0.78(0.46–1.32) 1.20(0.43–3.35) 1.13(0.51–2.51)
Maternal outcome
Cesarean section 1 1.06(0.94–1.21) 1.11(0.82–1.50) 1.19(0.95–1.49)
Gestational hypertension or preeclampsia 1 1.36(1.04–1.79)c 1.42(0.79–2.58) 1.70(1.11–2.60)c
Shoulder dystociab 1 0.61(0.27–1.34) 1.95(0.59–6.46) 2.02(0.78–5.23)
Third- or fourth-degree perineal lacerationb 1 1.04(0.78–1.37) 1.05(0.52–2.14) 0.98(0.55–1.74)
Postpartum hemorrhage 1 1.02(0.59–1.77) 1.26(0.39–4.08) 0.68(0.21–2.21)
Data are presented as adjusted odds ratios (95 % confidence intervals)
Odds ratios were adjusted for nulliparity, maternal age, body mass index at delivery, and delivery year. In addition to the above confounding factors, delivery type
(Cesarean section or not) was added for adjustment based on the perinatal outcome of postpartum hemorrhage
CC Carpenter-Coustan criteria, GDM gestational diabetes mellitus, NDDG National Diabetes Data Group criteria, NICU neonatal intensive care unit
aExcluding neonatal death
bOnly including vaginal delivery
c95 % confidence interval did not include 1
Lu et al. BMC Pregnancy and Childbirth  (2016) 16:231 Page 5 of 7
factors such as ethnicity and the BMI variable. We used
BMI at delivery to adjust the risk of pregnancy outcomes
instead of the pre-pregnancy BMI, because the latter infor-
mation was often missing in the database.
A similar study by Chou et al. in Taiwan enrolled
10,990 pregnancies in the urban area of northern Taiwan
[19]. The prevalence of CC-only-GDM in this study and
in our study was 4.4 and 2.2 %, respectively. The preva-
lence of NDDG-GDM in this study and in our study was
4.0 and 3.5 %, respectively. These findings demonstrated
that women with GDM based on the CC criteria but not
based on the NDDG criteria experienced a significant
increase in macrosomia compared with women without
GDM (4.5 vs. 2.3 %, P <0.05). Other outcomes showed
negative findings. Although both studies were conducted
in Taiwan, the urban area (northern Taiwan) studied by
Chou was different from the area examined in our study,
which enrolled pregnant women in a rural area in south-
ern Taiwan. Environmental factors, nutritional habits and
socioeconomic status are therefore potential confounding
factors. Furthermore, the maternal age and gestational age
at delivery in Chou’s study were different than in the
current study (32.0 ± 0.4 vs. 29.5 ± 4.6 years old; 38.5 ± 0.1
vs. 38.3 ± 1.4 gestational weeks).
Recent studies have focused on the new IADPSG cri-
teria, which have further broadened the diagnostic cri-
teria and stimulated debate about their cost-effectiveness
[24, 26–28]. The latest ACOG practice bulletin clearly
supports the two-step approach because the new IADPSG
criteria would significantly increase health care costs and
recommends that before the testing approach and diag-
nostic criteria for GDM are changed, the implications of
such changes should be studied [12]. We have used the
two-step approach for several years, and 6.2 % of GDM
according to the CC is appropriate and available for all
populations that are covered by National Health Insur-
ance. If the NDDG criteria were replaced by the CC cri-
teria, the number of pregnant women diagnosed with
GDM would increase by half, apparently increasing the
burden of prenatal care. However, the higher cost of ad-
verse neonatal outcomes on health care and society might
be reduced, including long-term poor outcomes such as
type 2 diabetes mellitus and the risk of childhood obesity
and abnormal glucose metabolism [29–31]. The cost-
effective estimation of such potential outcomes warrants
further study.
The study had several limitations; first, to the study
was a single-hospital retrospective study. Therefore, the
results obtained for Taiwanese women in the current
study should not be generalized. The existing evidence is
insufficient to build consensus regarding the diagnostic
criteria for GDM on pregnancy outcome [25, 32, 33].
Further prospective studies and reviews are needed.
Second, it would be interesting to expand our analyses by
applying the IADPSG criteria to those who screened as
positive and did not meet the NDDG criteria. However,
because IADPSG uses a one-step approach requiring the
full OGTT for the entire study population, we have no
data regarding the ideas in the current study. Despite
these limitations, the large sample of Asian women in-
volved represented a major strength of our study.
Conclusions
Our findings suggested that diagnosing GDM according
to the less strict CC criteria would detect a greater number
of adverse neonatal outcomes. Women who met the CC
criteria but not the NDDG criteria as well as women who
met the NDDG criteria were at greater risk for macroso-
mia, low birth weight, and admission to the NICU com-
pared with women who screened as negative. This evidence
adds important information to the current debate regarding
the diagnostic criteria for GDM on pregnancy outcomes.
Additional file
Additional file 1: Table S1. Comparison of our results with other
studies. (DOC 67 kb)
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